+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Colistin"

Antibiotic Resistance Global Market Report 2024 - Product Thumbnail Image

Antibiotic Resistance Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global and Chinese Colistin Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Colistin Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 148 Pages
  • China, Global
From
Antibiotic Drug Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotic Drug Resistance. Edition No. 1

  • Book
  • October 2019
  • 720 Pages
  • 6 Results (Page 1 of 1)
Loading Indicator

Colistin is an antibiotic used to treat serious bacterial infections, particularly those caused by Gram-negative bacteria. It is a polymyxin, a type of polypeptide antibiotic derived from the bacterium Paenibacillus polymyxa. Colistin is used in combination with other antibiotics to treat infections that are resistant to other antibiotics. It is also used to prevent infections in patients who are at high risk of developing them. Colistin is available in both oral and injectable forms. It is typically used in combination with other antibiotics, such as aminoglycosides, cephalosporins, and carbapenems. The use of colistin has increased in recent years due to the emergence of antibiotic-resistant bacteria. Colistin is produced by several pharmaceutical companies, including Pfizer, Merck, Sanofi, and AstraZeneca. It is also available as a generic drug from several generic drug manufacturers. In conclusion, Colistin is an important antibiotic used to treat serious bacterial infections, particularly those caused by Gram-negative bacteria. It is available in both oral and injectable forms and is produced by several pharmaceutical companies, including Pfizer, Merck, Sanofi, and AstraZeneca. Show Less Read more